🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sarah Larson

ORCID: 0000-0002-4335-2925

Also affiliated with UCLA Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Treatment‐free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response: Final 5‐year analysis of DASFREE”.

Treatment‐free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response: Final 5‐year analysis of DASFREE

British Journal of Haematology(2023)10.1111/bjh.18883

N/A

0.866DataRank · unranked

23 citations

Valentín García‐Gutiérrez, Antonio Jiménez‐Velasco, Sarah Larson, Susanne Saußele, Delphine Réa +8 more

Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny

Nature Communications(2025)10.1038/s41467-025-60816-z

N/A

0.281DataRank · unranked

4 citations

Nataly Naser Al Deen, Cole W. Peters, Begoña Comı́n-Anduix, Egmidio Medina, Cristina Puig-Saus +28 more

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013

npj Breast Cancer(2022)10.1038/s41523-022-00500-3

N/A

0DataRank · unranked

54 citations

Feng Gao, Cherease R. Street, Ina Chen, Donald W. Northfelt, Robert Wesolowski +21 more

CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naïve/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

medRxiv(2022)10.1101/2022.09.13.22279873

N/A

0DataRank · unranked

0 citations

Christopher M. Walthers, Brenda Ji, Sanaz N. Ghafouri, Jacob Naparstek, Jacqueline Trent +20 more

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100449

N/A

0DataRank · unranked

104 citations

Yang Zhou, Kwang Gi Kim, Yanni Zhu, Feiyang Ma, Jiaji Yu +24 more

Data from CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

(2023)10.1158/2159-8290.c.6549963

N/A

0DataRank · unranked

0 citations

Christopher M. Walthers, Brenda Ji, Sanaz N. Ghafouri, Jacob Naparstek, Jacqueline Trent +21 more

American Indian and Alaska Native recruitment strategies for health-related randomized controlled trials: A scoping review

PLoS ONE(2024)10.1371/journal.pone.0302562

N/A

0DataRank · unranked

8 citations

Sarah Larson, Olivia Rajpathy, Devon Olson, Nicole Redvers

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial

Nature Medicine(2023)10.1038/s41591-023-02273-z

N/A

0DataRank · unranked

76 citations

Michael P. Rettig, Reyka G. Jayasinghe, Keith Stockerl‐Goldstein, Sarah Larson, Illes Arpad +27 more

CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0964

N/A

0DataRank · unranked

102 citations

Christopher M. Walthers, Brenda Ji, Sanaz N. Ghafouri, Jacob Naparstek, Jacqueline Trent +21 more